Our Firm has advised Spark Institutional Equities and Avendus Capital in relation to the recently concluded stake sale of Syngene International by its promoter Biocon Limited through a block deal on the screen based trading platform of stock exchanges. Syngene is an integrated research, development and manufacturing organisation providing scientific services – from early discovery to commercial supply. Spark Institutional Equities and Avendus Capital were the sole broker and advisor for the transaction.
Deal value – over INR 2,240 crore (above USD 273 million)
INDUSLAW Team – Ravi Dubey (Partner), Anshul Roy (Principal Associate)